Minnesota HF 1246: Prescription Drug Price Transparency Act established, drug manufacturers required to submit drug price information to the commissioner of health, civil penalties provided, and report required.

Status: Author added Cantrell (as of 2020-05-11)

State: Minnesota · Session: 2019-2020 · Bill: HF 1246

Subjects: Drugs and Medicine, Health and Health Department, Popular Names

Sponsors: Morrison, Acomb, Bahner, Baker, Bernardy, Cantrell, Dehn, Elkins, Freiberg, Haley, Halverson, Hamilton, Hassan, Her, Hornstein, Howard, Kresha, Liebling, Long, Mann, Moller, Moran, Noor, Olson, Pinto

View Minnesota HF 1246 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.